Diacetylrhein For Osteoarthritis

Diacetylrhein For Osteoarthritis

NIP-004

≥ 98%

C19H12O8

368.2938

Diacetylrhein, also known as diacerein, serves as a significant inhibitor of IL-1 in osteoarthritis. It is a novel interleukin-1 (IL-1) inhibitor. Belonging to the anthraquinone class of compounds, it induces cartilage formation, possesses analgesic, anti-inflammatory, and antipyretic effects, significantly improves joint function in osteoarthritis patients, delays disease progression, reduces pain, enhances patients' quality of life, and demonstrates good safety. Clinically, it is primarily used for the treatment of osteoarthritis and has an antimicrobial effect.

Complies with relevant quality standards and regulations.
Soluble in organic solvents for versatile formulation options.
Ideal for the development of osteoarthritis treatments.

Pure diacerein powder is mainly used in the pharmaceutical industry to treat osteoarthritis.
It is also utilized in medical research and development related to musculoskeletal disorders.
It may have applications in dietary supplements aimed at joint health and mobility.

Raw material selection. Select high-quality raw materials to ensure the purity and efficacy of the final product.
Synthesis. Employ appropriate chemical reactions to synthesize diacerein, ensuring high purity and high yield.
Purification. Refine crude di-acetylrheum to remove impurities, yielding high-purity di-acetylrheum.
Drying. Dry purified di-acetylrheum to eliminate residual moisture, producing a free-flowing powder with desired physical properties.
Quality control. Conduct rigorous testing and analysis to ensure compliance with all quality standards.
Packaging. Package the product in suitable containers to protect against moisture, light exposure, and other potential degradation factors.

Light-yellow to brown-yellow powder.

Soluble in dimethyl sulfoxide, dimethylformamide,
slightly soluble in water, methanol, and chloroform.

2 years

25 kg/drum

Store in a cool, dry place away from direct sunlight.